In the course of our screening for new antibiotics we found that a strain of Papularia sphaerosperma (PERS.), HoHNEL*1), which belongs to the Deuteromycetes, produces a mixture of new antifungal antibiotics.2) Five structurally related components, namely papulacandins A, B, C, D and E were isolated and purified by chromatographic techniques. The major components present were papulacandins A, B
and C, which are strongly active against Candida albicans and several other yeasts, whereas papulacandins D and E are only minor components with lower activity. In this communication the fermentation, isolation, characterization and biological properties of the papulacandin complex are reported.
Fermentation
The antimicrobial activity of the culture broth was determined by the agar diffusion assay method with paper discs of 6-mm diameter. The test organism was Candida albicans K 1133.
For the best production of the papulacandins a well sporulated agar slant culture of Papadaria sphaerosperma was used as a seed culture. The slant was washed with 5 ml of a 0.2 molar SoRENSEN phosphate buffer pH 7. The resulting mycelial-spore suspension was poured into a 500-m1 Erlenmeyer flask with one baffle.
It contained 100 ml of nutrient broth of the following composition: 2% soybean, 2% mannitol. The pH was adjusted before sterilization to 8.2 with I N NaOH. The flask was shaken at 250 r.p.m. and 23°C for 48 hours. For a second preculture, three 2-liter Erlenmeyer flasks with four baffles, each containing 500 ml of the soybean medium mentioned above, were inoculated with 25 ml each of the culture broth from the first preculture. The incubation was carried out at 120 r.p.m. and 23°C for 48 hours. This second flask preculture (1.5 liters) served as an inoculum for the fermenter preculture. The optimal production of the papulacandins occurred after about 60 hours, when the pH of the culture broth reached 6.7.
Isolation and Purification
The antibiotic complex was isolated from both the culture filtrate and the mycelium by extraction at pH 8.6 with ethyl acetate and methanol, respectively. The methanol extract from the mycelium was concentrated to an aqueous oil which was again extracted at pH 8.4 with ethyl acetate. Both ethyl acetate extracts were combined and concentrated to an oily residue.
The crude extract was dissolved in 85 % aqueous methanol and lipophilic impurities were removed by extraction with petroleum ether and heptane. The methanol extract was concentrated again leaving the crude antibiotic mixture.
Further separation of the complex into its components was achieved by chromatography on silicagel with chloroform and increasing amounts of methanol as eluents.
Highly purified papulacandins A Fig 1977 31,200) .
In the mass spectrum no molecular ion is visible. The infrared spectrum (Fig. 2) shows the presence of unsaturated carbonyl groups (1690, 1640, 1615 cm-') and hydroxyl groups (3500 cm-'). In the 360 MHz-NMR-spectrum (Fig. 3 ) the signals of 3 methyl groups on saturated carbons at 0.9 ppm and one vinylic methyl group at 1.7 ppm are present. The signals in the region between 5.5 and 8 ppm The absence of any free carboxyl groups indicates that two phenolic hydrogens could be present. 1977 Hydrogenation of the antibiotic gave an uptake of 7 moles of hydrogen.
In the 1H-NMR-spectrum of tetradecahydropapulacandin B all the olefinic hydrogens and the vinylic methyl group disappeared.
The two signals at 6.2 ppm may be attributed to two aromatic protons in meta-position.
From elementary analysis and the 13C-NMR spectrum of papulacandin B and its nonaacetate, and from preliminary degradation experiments, the molecular formula was determined to be C47H64O17.
Structural studies of papulacandin B by degradation experiments are in progress and will be reported elsewhere.
Biological Properties
The papulacandins have a high specific activity against yeasts. They are largely inactive against filamentous fungi and they show, with the exception of a slight activity against some gram-positive bacteria, no activity against bacteria and protozoa. The antimicrobial spectrum of the papulacandins is shown in Table 3 .
The papulacandins A and C are about one half as active as papulacandin B, whereas the papulacandins D and E show a much lower antimicrobial activity.
Against Candida albicans papulacandin B exhibits a lower MIC than the well known antifungal substances amphotericin, nystatin and clotrimazol (see Table 3 ).
No cross resistance exists between the papulacandins and the polyenes5) or the new antifungal antibiotic conocandin41 or the chemotherapeutics clotrimazol6) and miconazol7). A partial cross resistance, possibly based on a similar mode of action, has been seen between papulacandin B and echinocandin B, a new peptide antibiotic active against yeasts and fungi. 3, 8) There is evidence that the site of action of papulacandin B is the structural glucan of the yeast's cell wall.2) During our observations papulacandin B indicated a fungistatic action in the following test system: A proper MIC determination by a 1 : 2 serial dilution test with Candida albicans in Mycophil broth was carried out. The contents of the last four tubes showing no visible growth, were filtered separately through 0.45 Ft Millipore filter discs. After washing out the remaining antibiotic with Mycophil broth -10 times of the original volume were used -the filter discs were incubated on Mycophil agar for 24 hours .
No growth on the discs was observed at concentrations higher than ten times the MIC level, while full growth was observed at lower levels. Therefore papulacandin was classified as a fungistatic antibiotic. On the other hand, by examining liquid cultures under the microscope, a fungicidal activity at MIC levels was also observed, though only on growing cells. The growing buds of these cells burst under the influence of papulacandin B, whereas resting cells remain unaffected.
In a soft agar diffusion system with a monolayer of chicken fibroblasts, a 5 % solution of papulacandin B in dimethylformamide showed a very slight cytotoxicity. The fibroblasts in a 2-mm circle around a 6-mm Whatman filter paper disc, placed on top of the soft agar, were unable to accumulate Neutral Red, thus indicating a slight cytotoxicity of the substance.
The acute toxicity of papulacandins A and B in mice is very low. The LD50 (s.c.) is above 1,000 mg/ kg. In in vivo tests a generalized infection of mice with Candida albicans, produced by an i.v. injection of 2 x 106 viable cells/mouse, was cured by a subcutaneous application of papulacandin A or B. The ED50 was 180 and 80 mg/kg respectively. No curing effect was observed in oral treatments up to 1,000 mg/kg. VOL. XXX NO. 4 THE JOURNAL OF ANTIBIOTICS At 23°C the stability of a 0.1 % solution of papulacandin B in Mycophil broth is highest between pH 5 and pH 7. At 4°C the solution is stable for more than 3 weeks over a much wider pH range: pH 3-pH 9.
Experimental
Derivatives Acetylation: Papulacandin B (250 mg) was treated with 2 ml acetic anhydride and 2 ml pyridine for 3 hours at room temperature. The reaction mixture was then evaporated in vacuum and chromatographed on 30 g silica-get with chloroform -methanol (99: 1) as solvent giving 200 mg of colorless, amorphous papulacandin B nonaacetate after precipitation from ether -hexane.
[a]22=D=+6±1' (c 0.865, CHC13); IR vma.x°i2 : 1755 cm-1 (C 0, sat.), 1645 cm-1, 1620 cm-1 (C=C), 1225 cm-' (C-O-C); NMR (360 MHz, CDC13) : 9 visible acetate groups between 1.75 and 2.40 ppm; UV ImzHaox (s) : 216 nm (23,200), 242 nm (25,600), 268 nm (27,600), 295 nm (shoulder). Calculated for C63H82O23 C 61.02 %, H 6.46 Found C 60.83 %, H 6.49 Hydrogenation: Papulacandin B (500 mg) was hydrogenated with 100 mg PtO2 in 100 ml ethyl alcohol. After 4 hours at room temperature the uptake was 7.1 equivalents of hydrogen. The solution was filtered and evaporated to dryness. Chromatography on 100 g silica-gel with chloroformmethanol (9: 1) as solvent and precipitation from acetone -ether -hexane afforded 230 mg white amorphous tetradecahydropapulacandin B.
